{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:13:21Z","timestamp":1776942801537,"version":"3.51.4"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011099","name":"Deutsche Gesellschaft f\u00fcr Internationale Zusammenarbeit","doi-asserted-by":"publisher","award":["81281913"],"award-info":[{"award-number":["81281913"]}],"id":[{"id":"10.13039\/501100011099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"German Center for Infection Research","doi-asserted-by":"publisher","award":["8008803909"],"award-info":[{"award-number":["8008803909"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Loiasis, a filarial vector-borne disease, is common in rural West and Central Africa. Benzimidazole derivatives albendazole and mebendazole are recommended as alternative treatments due to their perceived safety in hypermicrofilaremic patients. There is growing evidence that benzimidazoles might also lead to Loa loa-associated encephalopathy. In this systematic review we analyzed all available evidence of benzimidazole-associated encephalopathy.<\/jats:p>\n                  <jats:p>Literature was systematically searched in PubMed, Google Scholar, and WHO-VigiBase\u00ae, including conference abstracts and consultation of experts.<\/jats:p>\n                  <jats:p>Six potential cases of benzimidazole-associated encephalopathy, including 2 fatalities, were identified among microfilaremic loiasis patients. Due to the limited global use of prolonged benzimidazole regimens for loiasis, the number of encephalopathy cases identified raises significant safety concerns, challenging the rationale of their use. Further research on mechanisms and safer alternative regimens is urgently needed.<\/jats:p>","DOI":"10.1093\/ofid\/ofaf700","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T12:33:22Z","timestamp":1763382802000},"source":"Crossref","is-referenced-by-count":1,"title":["<i>Loa loa<\/i>\n                    Encephalopathy Following Treatment With Benzimidazole Derivatives: A Systematic Review"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0027-0715","authenticated-orcid":false,"given":"Saskia Dede","family":"Davi","sequence":"first","affiliation":[{"name":"Center for Tropical Medicine, Bernhard-Nocht Institute for Tropical Medicine & I. Dept. of Medicine University Medical Center Hamburg-Eppendorf , Hamburg ,","place":["Germany"]},{"name":"German Centre for Infection Research, Partner Site Hamburg-L\u00fcbeck-Borstel-Riems, Hamburg-L\u00fcbeck-Borstel-Riems , Hamburg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Nordmann","sequence":"additional","affiliation":[{"name":"Center for Tropical Medicine, Bernhard-Nocht Institute for Tropical Medicine & I. Dept. of Medicine University Medical Center Hamburg-Eppendorf , Hamburg ,","place":["Germany"]},{"name":"German Centre for Infection Research, Partner Site Hamburg-L\u00fcbeck-Borstel-Riems, Hamburg-L\u00fcbeck-Borstel-Riems , Hamburg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lillian Rene","family":"Endamne","sequence":"additional","affiliation":[{"name":"Center for Tropical Medicine, Bernhard-Nocht Institute for Tropical Medicine & I. Dept. of Medicine University Medical Center Hamburg-Eppendorf , Hamburg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8213-4912","authenticated-orcid":false,"given":"Wilfrid","family":"Ndzebe Ndoumba","sequence":"additional","affiliation":[{"name":"Centre de Recherches M\u00e9dicales de Lambar\u00e9n\u00e9, Lambar\u00e9n\u00e9 , Gabon Lambar\u00e9n\u00e9 ,","place":["Gabon"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u00f4la A","family":"Adegnika","sequence":"additional","affiliation":[{"name":"Centre de Recherches M\u00e9dicales de Lambar\u00e9n\u00e9, Lambar\u00e9n\u00e9 , Gabon Lambar\u00e9n\u00e9 ,","place":["Gabon"]},{"name":"Institute for Tropical Medicine, University of T\u00fcbingen , T\u00fcbingen ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4693-4207","authenticated-orcid":false,"given":"Selidji T","family":"Agnandji","sequence":"additional","affiliation":[{"name":"Centre de Recherches M\u00e9dicales de Lambar\u00e9n\u00e9, Lambar\u00e9n\u00e9 , Gabon Lambar\u00e9n\u00e9 ,","place":["Gabon"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Lell","sequence":"additional","affiliation":[{"name":"Centre de Recherches M\u00e9dicales de Lambar\u00e9n\u00e9, Lambar\u00e9n\u00e9 , Gabon Lambar\u00e9n\u00e9 ,","place":["Gabon"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Gottfried","family":"Kremsner","sequence":"additional","affiliation":[{"name":"Centre de Recherches M\u00e9dicales de Lambar\u00e9n\u00e9, Lambar\u00e9n\u00e9 , Gabon Lambar\u00e9n\u00e9 ,","place":["Gabon"]},{"name":"Institute for Tropical Medicine, University of T\u00fcbingen , T\u00fcbingen ,","place":["Germany"]},{"name":"German Center for Infection Research, Partner Site T\u00fcbingen , T\u00fcbingen ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2658-8706","authenticated-orcid":false,"given":"Ghyslain","family":"Mombo-Ngoma","sequence":"additional","affiliation":[{"name":"German Centre for Infection Research, Partner Site Hamburg-L\u00fcbeck-Borstel-Riems, Hamburg-L\u00fcbeck-Borstel-Riems , Hamburg ,","place":["Germany"]},{"name":"Centre de Recherches M\u00e9dicales de Lambar\u00e9n\u00e9, Lambar\u00e9n\u00e9 , Gabon Lambar\u00e9n\u00e9 ,","place":["Gabon"]},{"name":"Department of Implementation Research, Bernhard-Nocht Institute for Tropical Medicine , Hamburg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rella","family":"Zoleko Manego","sequence":"additional","affiliation":[{"name":"Center for Tropical Medicine, Bernhard-Nocht Institute for Tropical Medicine & I. Dept. of Medicine University Medical Center Hamburg-Eppendorf , Hamburg ,","place":["Germany"]},{"name":"German Centre for Infection Research, Partner Site Hamburg-L\u00fcbeck-Borstel-Riems, Hamburg-L\u00fcbeck-Borstel-Riems , Hamburg ,","place":["Germany"]},{"name":"Centre de Recherches M\u00e9dicales de Lambar\u00e9n\u00e9, Lambar\u00e9n\u00e9 , Gabon Lambar\u00e9n\u00e9 ,","place":["Gabon"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Ramharter","sequence":"additional","affiliation":[{"name":"Center for Tropical Medicine, Bernhard-Nocht Institute for Tropical Medicine & I. Dept. of Medicine University Medical Center Hamburg-Eppendorf , Hamburg ,","place":["Germany"]},{"name":"German Centre for Infection Research, Partner Site Hamburg-L\u00fcbeck-Borstel-Riems, Hamburg-L\u00fcbeck-Borstel-Riems , Hamburg ,","place":["Germany"]},{"name":"Centre de Recherches M\u00e9dicales de Lambar\u00e9n\u00e9, Lambar\u00e9n\u00e9 , Gabon Lambar\u00e9n\u00e9 ,","place":["Gabon"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"2025120910313579300_ofaf700-B1","doi-asserted-by":"crossref","first-page":"010413","DOI":"10.7189\/jogh.08.010413","article-title":"Behavioural and clinical predictors for loiasis","volume":"8","author":"Mischlinger","year":"2018","journal-title":"J Glob Health"},{"key":"2025120910313579300_ofaf700-B2","doi-asserted-by":"crossref","first-page":"e0010793","DOI":"10.1371\/journal.pntd.0010793","article-title":"Distinct loiasis infection states and associated clinical and hematological manifestations in patients from Gabon. Specht S, editor","volume":"16","author":"Veletzky","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"2025120910313579300_ofaf700-B3","first-page":"S1473","article-title":"The African eye worm: current understanding of the epidemiology, clinical disease, and treatment of loiasis","volume":"23","author":"Ramharter","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2025120910313579300_ofaf700-B4","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1474-4422(13)70139-X","article-title":"Loa loa: neglected neurology and nematodes","volume":"12","author":"Holmes","year":"2013","journal-title":"Lancet Neurol"},{"key":"2025120910313579300_ofaf700-B5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.7861\/clinmedicine.18-2-155","article-title":"Acute encephalitis \u2013 diagnosis and management","volume":"18","author":"Ellul","year":"2018","journal-title":"Clin Med"},{"key":"2025120910313579300_ofaf700-B6","first-page":"348","volume-title":"Non-flavivirus encephalitis","author":"Paul","year":"2011"},{"key":"2025120910313579300_ofaf700-B7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4269\/ajtmh.1998.58.461","article-title":"Three probable cases of loa loa encephalopathy following ivermectin treatment for onchocerciasis","volume":"58","author":"Ngoumou","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"2025120910313579300_ofaf700-B8","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/cid\/cix016","article-title":"Posttreatment reactions after single-dose diethylcarbamazine or ivermectin in subjects with loa loa infection","volume":"64","author":"Herrick","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2025120910313579300_ofaf700-B9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/infdis\/168.1.202","article-title":"Albendazole in human loiasis: results of a double-blind, placebo-controlled trial","volume":"168","author":"Klion","year":"1993","journal-title":"J Infect Dis"},{"key":"2025120910313579300_ofaf700-B10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.medcli.2010.02.003","article-title":"Meningoencefalitis por loa loa secundaria a tratamiento con mebendazol","volume":"136","author":"Velilla Moliner","year":"2011","journal-title":"Med Cl\u00edn"},{"key":"2025120910313579300_ofaf700-B11","doi-asserted-by":"crossref","first-page":"102006","DOI":"10.1016\/j.parint.2019.102006","article-title":"Encephalopathy in a patient with loiasis treated with albendazole: a case report","volume":"75","author":"Volpicelli","year":"2019","journal-title":"Parasitol Int"},{"key":"2025120910313579300_ofaf700-B12","doi-asserted-by":"crossref","first-page":"e0009354","DOI":"10.1371\/journal.pntd.0009354","article-title":"Serious adverse reactions associated with ivermectin: a systematic pharmacovigilance study in sub-saharan Africa and in the rest of the world. Wanji S, editor","volume":"15","author":"Campillo","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"2025120910313579300_ofaf700-B13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40779-020-00238-8","article-title":"Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?","volume":"7","author":"Ma","year":"2020","journal-title":"Military Med Res"},{"key":"2025120910313579300_ofaf700-B14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0001-706X(00)00159-5","article-title":"Encephalopathy following loa loa treatment with albendazole","volume":"78","author":"Blum","year":"2001","journal-title":"Acta Trop"},{"key":"2025120910313579300_ofaf700-B15","doi-asserted-by":"crossref","first-page":"e01033","DOI":"10.1016\/j.idcr.2020.e01033","article-title":"Albendazole-related loa loa encephalopathy","volume":"23","author":"M\u00e9tais","year":"2021","journal-title":"IDCases"},{"key":"2025120910313579300_ofaf700-B16","doi-asserted-by":"crossref","first-page":"e0011584","DOI":"10.1371\/journal.pntd.0011584","article-title":"Efficacy, safety, and tolerability of albendazole and ivermectin based regimens for the treatment of microfilaraemic loiasis in adult patients in Gabon: a randomized controlled assessor blinded clinical trial. Ionica AM, editor","volume":"17","author":"Zoleko-Manego","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"key":"2025120910313579300_ofaf700-B17","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1475-2883-2-S1-S2","article-title":"Scientific working group on serious adverse events in loa loa endemic areas. Report of a scientific working group on serious adverse events following mectizan(R) treatment of onchocerciasis in loa loa endemic areas","volume":"2","author":"Scientific Working Group on Serious Adverse Events in Loa Loa endemic areas","year":"2003","journal-title":"Filaria J"},{"key":"2025120910313579300_ofaf700-B18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40360-019-0327-5","article-title":"Analysis of severe adverse effects following community-based ivermectin treatment in the democratic Republic of Congo","volume":"20","author":"Makenga Bof","year":"2019","journal-title":"BMC Pharmacol Toxicol"},{"key":"2025120910313579300_ofaf700-B19","doi-asserted-by":"crossref","first-page":"100582","DOI":"10.1016\/j.eclinm.2020.100582","article-title":"Individual risk of post-ivermectin serious adverse events in subjects infected with loa loa","volume":"28","author":"Chesnais","year":"2020","journal-title":"EClinicalMedicine"},{"key":"2025120910313579300_ofaf700-B20","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41467-024-45027-2","article-title":"Predicting the risk and speed of drug resistance emerging in soil-transmitted helminths during preventive chemotherapy","volume":"15","author":"Coffeng","year":"2024","journal-title":"Nat Commun"},{"key":"2025120910313579300_ofaf700-B21","doi-asserted-by":"crossref","first-page":"e0004492","DOI":"10.1371\/journal.pntd.0004492","article-title":"Effect of two or six doses 800\u2005mg of albendazole every two months on loa loa microfilaraemia: a double blind, randomized, placebo-controlled trial. Lammie PJ, editor","volume":"10","author":"Kamgno","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"2025120910313579300_ofaf700-B22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1051\/parasite\/200209159","article-title":"Effect of a single dose (600\u2005mg) of albendazole on Loa loa microfilaraemia","volume":"9","author":"Kamgno","year":"2002","journal-title":"Parasite"},{"key":"2025120910313579300_ofaf700-B23","doi-asserted-by":"crossref","first-page":"e0006917","DOI":"10.1371\/journal.pntd.0006917","article-title":"Comparison of different drug regimens for the treatment of loiasis\u2014a TropNet retrospective study. Geary TG, editor","volume":"12","author":"Gobbi","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"2025120910313579300_ofaf700-B24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/00034983.1987.11812120","article-title":"The use of mebendazole in the treatment of filariases due to Loa loa and Mansonella perstans","volume":"81","author":"Hoegaerden","year":"1987","journal-title":"Ann Trop Med Parasitol"},{"key":"2025120910313579300_ofaf700-B25","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3201\/eid2508.190011","article-title":"Efficacy of high-dose albendazole with ivermectin for treating imported loiasis, Italy","volume":"25","author":"Gobbi","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"2025120910313579300_ofaf700-B26","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1179\/000349802125001933","article-title":"Effects of a 3-day regimen of albendazole (800mg daily) on Loa loa microfilaraemia","volume":"96","author":"Tsague-Dongmo","year":"2002","journal-title":"Ann Trop Med Parasitol"},{"key":"2025120910313579300_ofaf700-B27","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/0035-9203(87)90156-8","article-title":"Failure of high dose mebendazole as a microfilaricide in patients with loiasis","volume":"81","author":"Buchard","year":"1987","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2025120910313579300_ofaf700-B28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4269\/ajtmh.2004.71.211","article-title":"Human loiasis in a Cameroonian village: a double-blind, placebo-controlled, crossover clinical trial of a three-day albendazole regimen","volume":"71","author":"Tabi","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"2025120910313579300_ofaf700-B29","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1475-2883-2-S1-S4","article-title":"Clinical picture, epidemiology and outcome of loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon","volume":"2","author":"Boussinesq","year":"2003","journal-title":"Filaria J"},{"issue":"Suppl 1","key":"2025120910313579300_ofaf700-B30","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/1475-2883-2-S1-S7","article-title":"Loa loa encephalopathy temporally related to ivermectin administration reported from onchocerciasis mass treatment programs from 1989 to 2001: implications for the future","volume":"2","author":"Twum-Danso","year":"2003","journal-title":"Filaria J"},{"key":"2025120910313579300_ofaf700-B31","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/S2666-5247(22)00331-7","article-title":"Evaluating post-treatment loa loa microfilarial densities to classify serious adverse events caused by ivermectin: a retrospective analysis","volume":"4","author":"Boull\u00e9","year":"2023","journal-title":"Lancet Microbe"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf700\/65487103\/ofaf700.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/12\/ofaf700\/65487103\/ofaf700.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/12\/ofaf700\/65487103\/ofaf700.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:31:46Z","timestamp":1765294306000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf700\/8340873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,11,26]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf700","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,11,24]]},"article-number":"ofaf700"}}